Zhang Jiayi, Zhao Lin, Zhou Yan, Ding Jianmin, Zhang Qian, Jing Xiang
The Third Central Clinical College of Tianjin Medical University, Tianjin, China.
Department of Ultrasound, Tianjin Institute of Hepatobiliary Disease, Tianjin Key Laboratory of Artificial Cell, Artificial Cell Engineering Technology Research Center of Public Health Ministry, Tianjin, China.
Transl Cancer Res. 2022 Aug;11(8):2523-2535. doi: 10.21037/tcr-22-244.
Thermal ablation is one of the first-line treatments for patients with hepatocellular carcinoma (HCC) with a massive potential of long-term cure. However, it is disadvantaged by the relatively high rate of postoperative recurrence. In this study, a comparison was performed in the prognostic performance between albumin-bilirubin (ALBI) grade and Child-Pugh (C-P) grade for those HCC patients undergoing thermal ablation.
A total of 467 patients undergoing thermal ablation as the initial therapy were recruited and retrospectively analyzed. Then, an investigation was carried out into the prognostic values of overall survival (OS) and recurrence free survival (RFS) through ALBI grade and C-P score, separately. Besides, propensity-score matching (PSM) was performed to adjust the significantly different patient characteristics for ALBI grade based on C-P A patients.
In the multivariate analysis, both ALBI and C-P grades were treated as independent prognostic factors for OS. Cox multivariate analysis was conducted to reveal that the independent risk factors for postoperative HCC recurrence included ALBI grade 2-3, multiple tumors, tumor size ≥2 cm, and age ≥65 years. Following PSM (1:1), both ALBI-1 and ALBI-2 groups were found to be well matched in all of the parameters involved. Depending on the ALBI grade (113 ALBI-1 113 ALBI-2), C-P A patients were reclassified into two risk groups for OS (P=0.0058) and RFS (P=0.012), respectively.
The conventional C-P classification, despite its necessity, is less effective in assessing preoperative liver dysfunction for HCC patients and subjected to some limitations. Characterized by simplicity and objectivity, the ALBI grade has demonstrated its greater prognostic value than C-P grade for HCC patients who underwent thermal ablation.
热消融是对具有长期治愈巨大潜力的肝细胞癌(HCC)患者的一线治疗方法之一。然而,其劣势在于术后复发率相对较高。在本研究中,对接受热消融的HCC患者的白蛋白-胆红素(ALBI)分级和Child-Pugh(C-P)分级的预后性能进行了比较。
共纳入467例接受热消融作为初始治疗的患者,并进行回顾性分析。然后,分别通过ALBI分级和C-P评分对总生存期(OS)和无复发生存期(RFS)的预后价值进行了研究。此外,进行倾向评分匹配(PSM)以根据C-P A患者调整ALBI分级中显著不同的患者特征。
在多变量分析中,ALBI和C-P分级均被视为OS的独立预后因素。进行Cox多变量分析以揭示术后HCC复发的独立危险因素包括ALBI 2-3级、多发肿瘤、肿瘤大小≥2 cm和年龄≥65岁。PSM(1:1)后,发现ALBI-1组和ALBI-2组在所有涉及的参数上均匹配良好。根据ALBI分级(113例ALBI-级、113例ALBI-2级),C-P A患者分别被重新分类为OS(P = 0.0058)和RFS(P = 0.012)的两个风险组。
传统的C-P分类尽管有其必要性,但在评估HCC患者术前肝功能障碍方面效果较差且存在一些局限性。ALBI分级以简单性和客观性为特征,已证明其对接受热消融的HCC患者的预后价值大于C-P分级。